Anti-TRAF6 antibody [EP591Y] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal TRAF6 antibody. Carrier free. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 14 publications.
View Alternative Names
RNF85, TRAF6, TNF receptor-associated factor 6, E3 ubiquitin-protein ligase TRAF6, Interleukin-1 signal transducer, RING finger protein 85, RING-type E3 ubiquitin transferase TRAF6
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
Overlay histogram showing HAP1 wildtype (green line) and HAP1-TRAF6 knockout cells (red line) stained with ab33915. The cells were fixed with 4% formaldehyde (10 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (ab33915, 0.1μg/ml) for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) preadsorbed (ab150081) at 1/2000 dilution for 30 min at 22°C. A rabbit IgG isotype control antibody (ab172730) was used at the same concentration and conditions as the primary antibody (HAP1 wildtype - black line, HAP1-TRAF6 knockout - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity). Acquisition of >5,000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab33915).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
This IHC data was generated using the same anti-TRAF6 antibody clone, EP591Y, in a different buffer formulation (cat# ab33915).
Immunohistochemical analysis of paraffin-embedded human colon adenocarcinoma using anti-TRAF6 (ab33915)
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
AbReview22245****
Flow Cytometry (Intracellular) - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
ab33915 staining TRAF6 in Human platelet cells by intracellular flow cytometry.Cells were fixed in paraformaldehyde and permeabilized using 0.1% Triton-X-100 in 2% BSA for 15 minutes. Primary antibody used at a 1/200 dilution and incubated for 16 hours at 4°C. The secondary antibody used was an Alexa Fluor®488 conjugated chicken anti-rabbit IgG (H+L) at a 1/500 dilution.
P : permeabilized US : Unstained (Red Peak) IGG RB : IgG Rabbit (Blue Peak) TRAF6 Ab (Green Peak)This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab33915).
This image is courtesy of an anonymous Abreview.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
Intracellular Flow Cytometry analysis of Jurkat (human acute T cell leukemia) cells labeling TRAF6 with purified ab33915 at 1/240 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) was used as the unlabeled control.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab33915).
- WB
Lab
Western blot - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
This data was developed using the same antibody clone in a different buffer formulation (ab33915).
Lanes 1- 4 : Merged signal (red and green). Green - ab33915 observed at 65 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab33915 was shown to react with TRAF6 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab266009 (knockout cell lysate ab257760) was used. Wild-type HeLa and TRAF6 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab33915 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TRAF6 antibody [EP591Y] (<a href='/en-us/products/primary-antibodies/traf6-antibody-ep591y-ab33915'>ab33915</a>) at 1/2000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
TRAF6 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human TRAF6 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-traf6-knockout-hela-cell-line-ab266009'>ab266009</a>)
Lane 3:
HAP1 cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Predicted band size: 60 kDa
Observed band size: 65 kDa
false
- WB
Unknown
Western blot - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
This WB data was generated using the same anti-TRAF6 antibody clone, EP591Y, in a different buffer formulation (cat# ab33915).
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : TRAF6 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lane 4 : HEK293 whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab33915 observed at 65 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab33915 was shown to specifically react with TRAF6 in wild-type cells as signal was lost in TRAF6 knockout HAP1 cells. Wild-type and TRAF6 knockout samples were subjected to SDS-PAGE. ab33915 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 2000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging
All lanes:
Western blot - Anti-TRAF6 antibody [EP591Y] (<a href='/en-us/products/primary-antibodies/traf6-antibody-ep591y-ab33915'>ab33915</a>)
Predicted band size: 60 kDa
false
- WB
CiteAb
Western blot - Anti-TRAF6 antibody [EP591Y] - BSA and Azide free (AB218575)
TRAF6 western blot using anti-TRAF6 antibody [EP591Y] - BSA and Azide free ab218575. Publication image and figure legend from Casella, C. R. & Mitchell, T. C., 2013, PLoS One, PubMed 23638128.
ab218575 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab218575 please see the product overview.
Reduced MyD88-associated signaling by sMLA.Mouse BMDC were treated with 100 ng/ml sMLA or sDLA for the indicated times, lysed and either immunoblots (A,C) or immunoprecipitation (B) were performed on the lysates. A) Immunoblots were probed for IRAK1 and β-actin. A representative gel is depicted with a graph that shows the mean +/- SEM from 5 experiments in which IRAK1 levels were normalized to β-actin levels and vehicle control (VC, measured at 15 min.). B) Lysates were immunoprecipitated with IRAK1 antibodies and immunoblotted with antibodies for TRAF6 and IRAK1. The graph shows mean +/- SEM from 8 experiments with at least 5 data points per time point. TRAF6 levels were normalized based on IRAK1 levels and VC (5 min. time point). C) Left, Immunoblots were probed for phosphoERK 1/2 (Thr202/Tyr204), stripped and re-probed for ERK total, then β-actin. Shown are the mean +/- SEM from 5 experiments with levels of pERK1/2 normalized to ERK total and VC (15 min. time point). Right, immunoblots were probed for IκBα stripped and probed for β-actin. Shown are the mean +/- SEM from 4 experiments with levels of IκBα normalized to β-actin and VC (5 min. time point). Two way ANOVAs with Sidak's multiple comparisons were performed for A and C and two tailed paired T test for B. Asterisks indicate a significant differences between sMLA and sDLA at the indicated time points with * p<0.05, ** p<0.01 and, **** p<0.001, respectively.
false
Related conjugates and formulations (8)
-
Anti-TRAF6 antibody [EP591Y]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-TRAF6 antibody [EP591Y]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-TRAF6 antibody [EP591Y]
-
578 PE
PE Anti-TRAF6 antibody [EP591Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-TRAF6 antibody [EP591Y]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-TRAF6 antibody [EP591Y]
-
660 APC
APC Anti-TRAF6 antibody [EP591Y]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-TRAF6 antibody [EP591Y]
Reactivity data
Product details
ab218575 is the carrier-free version of ab33915.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRAF6 plays a critical role in regulating immune and inflammatory responses. It acts within a complex often associating with other signaling proteins such as IRAK1 and TAK1 to activate downstream kinases like IKK and JNK. These signaling pathways lead to the activation of transcription factors such as NF-kB and AP-1 which regulate the expression of genes involved in inflammation and immune responses. TRAF6 is an important modulator of adaptive and innate immunity influencing both the maturation of immune cells and the body's response to infection.
Pathways
TRAF6 significantly contributes to the NF-kB and MAPK signaling pathways. In the NF-kB pathway TRAF6 mediates signal transduction following TLR engagement interacting with proteins such as MyD88 and RIP1 to drive inflammatory cytokine production. In the MAPK pathway it associates predominantly with TAK1 to facilitate the phosphorylation and activation of downstream kinases. These pathways are essential for transmitting signals from cell surface receptors to the nucleus controlling the magnitude of immune signaling and cellular stress responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 12:709604 PubMed34489703
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cellular immunology 353:104115 PubMed32388054
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 7:11292 PubMed27068814
2016
Applications
Unspecified application
Species
Mouse
Archives of biochemistry and biophysics 567:13-21 PubMed25575785
2015
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 9:e104323 PubMed25116007
2014
Applications
WB
Species
Mouse
Blood cancer journal 4:e183 PubMed24531446
2014
Applications
WB
Species
Human
PloS one 8:e62622 PubMed23638128
2013
Applications
WB
Species
Mouse
The international journal of biochemistry & cell b 45:1399-409 PubMed23608519
2013
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 13:981-90 PubMed22842344
2012
Applications
Unspecified application
Species
Unspecified reactive species
Biomaterials 33:6559-69 PubMed22704844
2012
Applications
Flow Cyt, ICC/IF
Species
Mouse, Mouse
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com